S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Fund/Adar1 Capital Management/Q2 2025

Adar1 Capital Management

Periodo: Q2 2025 · Depositato: 2025-08-14
Vedi su SEC EDGAR
AUM
$650M
Valore totale del portafoglio
Posizioni
210
Titoli dichiarati
Prima Posizione
KROS
11.0% $72.0M
Var. Trimestrali
+8 / -8
nuovi · usciti
⚠️Informativa sui Depositi 13F

I dati AUM mostrati sono calcolati sommando il valore di mercato dichiarato di tutte le posizioni nei depositi SEC 13F-HR — non rappresentano il patrimonio effettivo gestito dal fondo.

  • Escluse liquidità, obbligazioni, private equity, posizioni corte e azioni estere non soggette all'obbligo di dichiarazione.
  • Per le opzioni PUT e CALL, il Valore dichiarato è il valore nozionale delle azioni sottostanti — non il premio pagato. Ciò sovrastima significativamente il capitale effettivamente a rischio.
  • Il patrimonio reale del fondo è tipicamente superiore e include strategie, strumenti e posizioni che non compaiono mai in un 13F.
  • I depositi 13F riguardano i gestori istituzionali con ≥$100M in titoli 13F. Le posizioni riflettono le partecipazioni a fine trimestre, divulgate entro 45 giorni dalla fine del periodo.

Dati provenienti da SEC EDGAR. Questo tracker è a scopo puramente informativo e non costituisce consulenza finanziaria.

Partecipazioni in Portafoglio

Prime 30 posizioni

⚠️ Performance % calcolata dalla data di deposito ( 2025-08-14) si riferisce al titolo sottostante — non al P&L del derivato.
TickerEmittenteNozionalePortafoglio %Al DepositoOra (Fine Giornata)Dal DepositoAllocazione
KROSKEROS THERAPEUTICS INC$72.0M11.03%$13.35$11.26-15.7%
11.0%
PTGXPROTAGONIST THERAPEUTICS INC$52.4M8.04%$55.27$131.62+138.1%
8.0%
BOXXEA SERIES TRUST$38.0M5.83%$112.68$117.22+4.0%
5.8%
ZLABZAI LAB LTD$29.7M4.56%$34.97$19.12-45.3%
4.6%
SPYPUTSPDR S&P 500 ETF TR$25.0M3.84%$611.08$744.78+21.9%
3.8%
ABVXABIVAX SA$23.5M3.60%$7.65$144.65+1790.8%
3.6%
ROIVROIVANT SCIENCES LTD$21.9M3.35%$11.27$35.13+211.7%
3.4%
PRTAPROTHENA CORP PLC$20.5M3.14%$6.07$9.69+59.6%
3.1%
CYTKCYTOKINETICS INC$19.2M2.95%$33.04$86.49+161.8%
3.0%
SPYSPDR S&P 500 ETF TR$14.0M2.15%$611.08$744.78+21.9%
2.1%
CGONCG ONCOLOGY INC$13.6M2.09%$26.00$70.36+170.6%
2.1%
BILSPDR SERIES TRUST$12.4M1.91%$88.26$91.44+3.6%
1.9%
BBIOBRIDGEBIO PHARMA INC$11.2M1.72%$43.18$77.19+78.8%
1.7%
IKTINHIBIKASE THERAPEUTICS INC$10.0M1.53%$1.95$1.99+2.0%
1.5%
SEPNSEPTERNA INC$9.0M1.37%$10.57$34.00+221.7%
1.4%
ABUSARBUTUS BIOPHARMA CORP$8.7M1.34%$3.09$4.87+57.6%
1.3%
ETNB89BIO INC$8.6M1.32%
1.3%
IMVTIMMUNOVANT INC$8.6M1.31%$16.00$38.79+142.4%
1.3%
SVRASAVARA INC$8.2M1.26%$2.28$6.22+172.8%
1.3%
XENEXENON PHARMACEUTICALS INC$8.1M1.25%$31.30$60.96+94.8%
1.3%
BIOABIOAGE LABS INC$8.0M1.23%$4.13$25.10+507.8%
1.2%
PCSCPERCEPTIVE CAP SOLUTIONS COR$8.0M1.22%$10.62$11.00+3.6%
1.2%
AMLXAMYLYX PHARMACEUTICALS INC$7.7M1.18%$6.41$18.27+185.0%
1.2%
CTMXCYTOMX THERAPEUTICS INC$7.0M1.07%$2.27$3.82+68.3%
1.1%
TSHATAYSHA GENE THERAPIES INC$7.0M1.07%$2.31$6.53+182.7%
1.1%
SAGESAGE THERAPEUTICS INC$6.6M1.01%
1.0%
RAPTRAPT THERAPEUTICS INC$6.3M0.96%
1.0%
JANXCALLJANUX THERAPEUTICS INC$6.1M0.94%$23.10$15.54-32.7%
0.9%
AAMAA MISSION ACQUISITION CORP$6.0M0.92%
0.9%
IONSIONIS PHARMACEUTICALS INC$5.9M0.90%$39.51$81.80+107.0%
0.9%

Attività Trimestre su Trimestre

Q2 2025 vs. Q1 2025

Nuove Posizioni (8)

TickerEmittenteNozionaleDal Deposito
SPYSPDR S&P 500 ETF TR$25.0M+21.9%
PRTAPROTHENA CORP PLC$20.5M+59.6%
SPYSPDR S&P 500 ETF TR$14.0M+21.9%
RAPTRAPT THERAPEUTICS INC$6.3M
IONSIONIS PHARMACEUTICALS INC$5.9M+107.0%
VERVVERVE THERAPEUTICS INC$5.3M
CRMDCORMEDIX INC$2.2M
NAMSNEWAMSTERDAM PHARMA COMPANY$2.0M

Posizioni Chiuse (8)

TickerEmittenteNozionale
RAPTRAPT THERAPEUTICS INC$7.3M
ITCIINTRA-CELLULAR THERAPIES INC$6.3M
NVSNOVARTIS AG$5.6M
COHERUS BIOSCIENCES INC$5.5M
AVTEAEROVATE THERAPEUTICS INC$3.7M
BRIDGEBIO PHARMA INC$2.7M
PTCTPTC THERAPEUTICS INC$2.5M
CRGXCARGO THERAPEUTICS INC$1.4M

Aumentate (8)

TickerEmittenteNozionaleVar. AzioniDal Deposito
CTMXCYTOMX THERAPEUTICS INC$7.0M+6451.2%+68.3%
AVTXAVALO THERAPEUTICS INC$0.4M+947.3%
PCVXVAXCYTE INC$2.7M+665.9%
MLTXMOONLAKE IMMUNOTHERAPEUTICS$1.4M+532.6%
PHATPHATHOM PHARMACEUTICALS INC$0.5M+528.0%
ABOSACUMEN PHARMACEUTICALS INC$0.9M+526.7%
THRDTHIRD HARMONIC BIO INC$3.0M+522.9%
WVEWAVE LIFE SCIENCES LTD$0.6M+397.0%

Ridotte (8)

TickerEmittenteNozionaleVar. AzioniDal Deposito
RNXTRENOVORX INC$-0.5M-95.9%
FULCFULCRUM THERAPEUTICS INC$-1.1M-89.1%
SWTXSPRINGWORKS THERAPEUTICS INC$-8.0M-88.4%
SMMTSUMMIT THERAPEUTICS INC$-1.7M-88.0%
APGEAPOGEE THERAPEUTICS INC$-3.1M-82.8%
SPROSPERO THERAPEUTICS INC$-0.2M-82.0%
XNCRXENCOR INC$-3.6M-78.4%
JANXJANUX THERAPEUTICS INC$-5.7M-76.6%-32.7%
Torna agli Hedge Fund